NEU 0.26% $15.57 neuren pharmaceuticals limited

Share Price, page-3687

  1. 2,211 Posts.
    lightbulb Created with Sketch. 326
    Hi Tony,

    Hottod, has answered your first question, infact ACADIA has spent over one billion USD on R&D since 2019,
    Trofinetides take was AUD $300 million, as Little t, mentioned in a previous post.

    Your 2nd question,
    I don't believe ACADIA is the perfect company for ROW rights, I was suggesting that a company that
    Has spent $300 million on R&D and NDA would want to maximise their investment by bidding for ROW rights.
    Why give away all their hard work to a third party? The BOD will ultimately make the best decision for the SHs.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.57
Change
-0.040(0.26%)
Mkt cap ! $1.990B
Open High Low Value Volume
$15.83 $15.87 $15.20 $8.124M 524.8K

Buyers (Bids)

No. Vol. Price($)
1 64 $15.49
 

Sellers (Offers)

Price($) Vol. No.
$15.58 597 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.